Publications by authors named "Yong-Yu Yang"

Claim this Profile
S
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter Study.
Da-Long Yang, Ning Peng, Jun-Liang Nong, Kang Chen, Ze Su, Fu-Quan Yang, Yong-Yu Yang

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of radiological and pathological complete response following immune-based conversion therapy in patients with unresectable hepatocellular carcinoma (GUIDANCE004).
Da-Long Yang, Yi-He Yan, Yong-Cheng Lai, Ming-Song Wu, Xiao-Feng Dong, Fu-Quan Yang, Yong-Yu Yang

JHEP Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages.
Da-Long Yang, Lin Ye, Fan-Jian Zeng, Jie Liu, Hong-Bing Yao, Fu-Quan Yang, Yong-Yu Yang

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages.
Da-Long Yang, Lin Ye, Fan-Jian Zeng, Jie Liu, Hong-Bing Yao, Fu-Quan Yang, Yong-Yu Yang

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024.
Shu Wei Wong, Yong-Yu Yang, Hui Chen, Li Xie, Xi-Zhong Shen

Acta Pharmacol Sin· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressing MASH fibrotic progression by blocking succinate-GPR91 signaling in HSCs.
Li Xie, Hui Chen, Li Zhang, Yong-Yu Yang, Yuan Zhou

Hepatology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shenfushu granules attenuate diabetic kidney disease by inhibiting /protein kinase B/heparanase-mediated endothelial-mesenchymal transition.
Xi-Ding Yang, Si-Jia Ma, Da-Xiong Xiang, Yong-Yu Yang

World J Diabetes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manshenkang granules alleviate fibrosis in chronic renal failure rats by regulating the PDE4b/cAMP pathway.
Yong-Yu Yang, Nian-Chun Gong, Yan-Mei Peng, Zhou-Sheng Yang, Da-Xiong Xiang

J Ethnopharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics of Semaglutide: A Systematic Review.
Xi-Ding Yang, Yong-Yu Yang

Drug Des Devel Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes of gut microbiota in mouse models of metabolic dysfunction-associated steatohepatitis and its transition to hepatocellular carcinoma.
Yu-Li Wang, Chang Liu, Yong-Yu Yang, Li Zhang, Xiao Guo

FASEB J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic artery pseudoaneurysm: three case reports and literature review.
Yuan-Quan Zhao, Yong-Yu Yang, Si-Yang Yao, Xiao-Feng Dong

Front Med (Lausanne)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway.
Yong-Yu Yang, Rong-Rong Deng, Da-Xiong Xiang

Drug Des Devel Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
Li Xie, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Qiang Yang

Clin Mol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-β1/SMAD3-driven GLI2 isoform expression contributes to aggressive phenotypes of hepatocellular carcinoma.
Jia Ding, Yong-Yu Yang, Peng-Tao Li, Yue Ma, Li Zhang

Cancer Lett· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances.
Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu

Clin Mol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway.
Li Zhang, Yong-Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong

Clin Transl Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esculin ameliorates obesity-induced insulin resistance by improving adipose tissue remodeling and activating the IRS1/PI3K/AKT/GLUT4 pathway.
Yong-Yu Yang, Jing-Jing Qi, Si-Yi Jiang, Ling Ye

J Ethnopharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma.
Yuan Zhou, Li Zhang, Yue Ma, Li Xie, Yong-Yu Yang

Theranostics· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polydopamine-modification of a magnetic composite constructed from citric acid-cross-linked cyclodextrin and graphene oxide for dye removal from waters.
Qing-Di Hu, Hong-Liu Jiang, Kwok-Ho Lam, Zhi-Peng Hu, Zhi-Jie Liu, Yong-Yu Yang

Environ Sci Pollut Res Int· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential lipolytic regulators derived from natural products as effective approaches to treat obesity.
Xi-Ding Yang, Xing-Cheng Ge, Si-Yi Jiang, Yong-Yu Yang

Front Endocrinol (Lausanne)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis.
Yong-Yu Yang, Li Xie, Ning-Ping Zhang, Da Zhou, Tao-Tao Liu

Acta Pharmacol Sin· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications.
Xi-Ding Yang, Yong-Yu Yang

Front Endocrinol (Lausanne)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA).
Jing Chen, Shi-Fu Luo, Xin Yuan, Mi Wang, Hai-Jie Yu, Yong-Yu Yang

J Cell Biochem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases.
Chang Liu, Yu-Li Wang, Yong-Yu Yang, Ning-Ping Zhang, Chen Niu

FASEB J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piperazine ferulate prevents high-glucose-induced filtration barrier injury of glomerular endothelial cells.
Yong-Yu Yang, Zhuo Chen, Xi-Ding Yang, Rong-Rong Deng, Ling-Xing Shi

Exp Ther Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis